Anti-addiction Agents
- 3 March 2016
- book chapter
- Published by Springer Nature
- p. 351-372
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Smoking Cessation Pharmacogenetics: Analysis of Varenicline and Bupropion in Placebo-Controlled Clinical TrialsNeuropsychopharmacology, 2011
- High doses of oxycodone–naloxone combination may provide poor analgesiaSupportive Care in Cancer, 2011
- Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid UsersClinical Drug Investigation, 2009
- Population pharmacokinetic analysis of varenicline in adult smokersBritish Journal of Clinical Pharmacology, 2009
- Nicotine Chemistry, Metabolism, Kinetics and Biomarkers2009
- Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteersClinical Therapeutics, 2008
- AcamprosateDrugs, 1997
- NaltrexoneDrugs, 1988
- Clinical Pharmacokinetics of NicotineClinical Pharmacokinetics, 1987
- NaloxoneAnnals of Emergency Medicine, 1983